Testing effectiveness (Phase 2)Study completedNCT03693612What this trial is testingGSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid TumorsWho this might be right forNeoplasms GlaxoSmithKline 26
Early research (Phase 1)Ended earlyNCT05069935What this trial is testingFT538 in Combination With Monoclonal Antibodies in Advanced Solid TumorsWho this might be right forSolid Tumor, Adult Fate Therapeutics 16
Early research (Phase 1)Looking for participantsNCT07518043What this trial is testingHLX18 vs. OPDIVO® in Multiple Resected Solid TumorsWho this might be right forEsophageal and/or Cardia CancerMelanomaUrothelial Carcinoma (UC) Shanghai Henlius Biotech 174
Testing effectiveness (Phase 2)Ended earlyNCT04725331What this trial is testingA Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid TumorsWho this might be right forMetastatic CancerSoft Tissue SarcomaMerkel Cell Carcinoma+3 more Transgene 31
Early research (Phase 1)Study completedNCT02586987What this trial is testingAssess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid TumoursWho this might be right forLung CancerMelanomaHead and Neck Carcinoma+5 more AstraZeneca 58
Testing effectiveness (Phase 2)UnknownNCT00553683What this trial is testingCyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver CancerWho this might be right forBreast CancerColorectal CancerGastric Cancer+5 more Rutgers, The State University of New Jersey 50
Not applicableTemporarily pausedNCT06391099What this trial is testingKetogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney CancerWho this might be right forClinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Cutaneous MelanomaMetastatic Renal Cell Carcinoma+1 more Ohio State University Comprehensive Cancer Center 60
Early research (Phase 1)Study completedNCT02635672What this trial is testingPhase I Dose Escalation Study for VIP152 in Patients With Advanced CancerWho this might be right forNeoplasms Vincerx Pharma, Inc. 110
Early research (Phase 1)Study completedNCT00028496What this trial is testingVaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic CancerWho this might be right forAdenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Ended earlyNCT04789668What this trial is testingBintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain MetastasesWho this might be right forAnatomic Stage IV Breast Cancer AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Hematopoietic and Lymphoid Cell Neoplasm+11 more M.D. Anderson Cancer Center 8
Early research (Phase 1)Study completedNCT03107663What this trial is testing⁸⁹Zr-Df-IAB22M2C PET/CT in Patients With Selected Solid Malignancies or Hodgkin's LymphomaWho this might be right forPositron-Emission TomographyImmunomodulationMetastatic Solid Malignancies+1 more ImaginAb, Inc. 15
Testing effectiveness (Phase 2)Looking for participantsNCT07302347What this trial is testingPembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)Who this might be right forMalignant NeoplasmCarcinoma, Merkel CellLymphoma Merck Sharp & Dohme LLC 20
Large-scale testing (Phase 3)Study completedNCT00538850What this trial is testingFentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainWho this might be right forCancer INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00923169What this trial is testingPart 2 of Phase 1 Study of GC1008 to Treat Advanced Melanoma (Part 2 Will Only Accept and Treat Patients With Advanced Malignant Melanoma)Who this might be right forRenal Cell Carcinoma National Cancer Institute (NCI) 9
Early research (Phase 1)Study completedNCT00020267What this trial is testingVaccine Therapy in Treating Patients With Metastatic CancerWho this might be right forLung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00079131What this trial is testingOblimersen in Treating Patients With Merkel Cell CarcinomaWho this might be right forRecurrent Neuroendocrine Carcinoma of the SkinStage I Neuroendocrine Carcinoma of the SkinStage II Neuroendocrine Carcinoma of the Skin+2 more National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Ended earlyNCT02584829What this trial is testingLocalized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell CarcinomaWho this might be right forMerkel Cell Polyomavirus InfectionStage IV Merkel Cell Carcinoma AJCC v7 Fred Hutchinson Cancer Center 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT04291885What this trial is testingImmunotherapy Adjuvant Trial in Patients With Stage I-III Merkel Cell CarcinomaWho this might be right forMerkel Cell CarcinomaMerkel Cell Carcinoma, Stage IMerkel Cell Carcinoma, Stage II+3 more Melanoma and Skin Cancer Trials Limited 122
Early research (Phase 1)UnknownNCT03291002What this trial is testingStudy of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACCWho this might be right forMelanoma (Skin)Squamous Cell Carcinoma of the SkinCarcinoma, Squamous Cell of Head and Neck+1 more CureVac 98